Who Benefits from Radiotherapy for Gastric Cancer? A Meta-analysis.

Nitin Ohri; Madhur Garg; Santiago Aparo; Andreas Kaubisch; Wolfgang A. Tome; Timothy J. Kennedy; Shalom Kalnicki; Chandan Guha

Who Benefits from Radiotherapy for Gastric Cancer? A Meta-analysis.

Nitin Ohri, Madhur Garg, Santiago Aparo, Andreas Kaubisch, Wolfgang A. Tome, Timothy J. Kennedy, Shalom Kalnicki, Chandan Guha

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical / American Society of Clinical Oncology (ASCO) Annual Meeting
Volume	31
State	Published - Jun 2013

Disciplines

Medicine and Health Sciences
Pathology

Cite this

@article{2da9bec1aea042bfb1fb5fa280154fc4,

title = "Who Benefits from Radiotherapy for Gastric Cancer? A Meta-analysis.",

author = "Nitin Ohri and Madhur Garg and Santiago Aparo and Andreas Kaubisch and Tome, \{Wolfgang A.\} and Kennedy, \{Timothy J.\} and Shalom Kalnicki and Chandan Guha",

note = "4093 Background: Randomized trials have demonstrated significant survival benefits with the use of adjuvant (including neoadjuvant) chemotherapy or chemoradiotherapy for gastric cancer. The importance of adjuvant radiotherapy (RT) remains unclear. Here we perform an up-to-date meta-analysis of randomized trials testing the use of radiotherapy for resectable gastric cancer.",

year = "2013",

month = jun,

language = "American English",

volume = "31",

journal = "Journal of Clinical / American Society of Clinical Oncology (ASCO) Annual Meeting",

}

TY - JOUR

T1 - Who Benefits from Radiotherapy for Gastric Cancer? A Meta-analysis.

AU - Ohri, Nitin

AU - Garg, Madhur

AU - Aparo, Santiago

AU - Kaubisch, Andreas

AU - Tome, Wolfgang A.

AU - Kennedy, Timothy J.

AU - Kalnicki, Shalom

AU - Guha, Chandan

N1 - 4093 Background: Randomized trials have demonstrated significant survival benefits with the use of adjuvant (including neoadjuvant) chemotherapy or chemoradiotherapy for gastric cancer. The importance of adjuvant radiotherapy (RT) remains unclear. Here we perform an up-to-date meta-analysis of randomized trials testing the use of radiotherapy for resectable gastric cancer.

PY - 2013/6

Y1 - 2013/6

UR - https://ascopubs.org/doi/abs/10.1200/jco.2013.31.15_suppl.4093

M3 - Article

VL - 31

JO - Journal of Clinical / American Society of Clinical Oncology (ASCO) Annual Meeting

JF - Journal of Clinical / American Society of Clinical Oncology (ASCO) Annual Meeting

ER -

Who Benefits from Radiotherapy for Gastric Cancer? A Meta-analysis.

Disciplines

Other files and links

Cite this